Parallel Advisors’s Pulse Biosciences PLSE Stock Holding History

Parallel Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21	Closed	-$366	–	3629
2024 Q4	$366	Buy	+21	New	+$370	﹤0.01%	3285
2021 Q4	–	Sell	-250	Closed	-$5K	–	3244
2021 Q3	$5K	Hold	250	–	–	﹤0.01%	2376
2021 Q2	$4K	Hold	250	–	–	﹤0.01%	2386
2021 Q1	$6K	Hold	250	–	–	﹤0.01%	2139
2020 Q4	$6K	Hold	250	–	–	﹤0.01%	1977
2020 Q3	$3K	Hold	250	–	–	﹤0.01%	2211
2020 Q2	$2K	Hold	250	–	–	﹤0.01%	2220
2020 Q1	$1K	Sell	250 -750	-75%	-$7.78K	﹤0.01%	2316
2019 Q4	$13K	Hold	1,000	–	–	﹤0.01%	1620
2019 Q3	$15K	Hold	1,000	–	–	﹤0.01%	1501
2019 Q2	$13K	Hold	1,000	–	–	﹤0.01%	1475
2019 Q1	$18K	Hold	1,000	–	–	﹤0.01%	1273
2018 Q4	$11K	Hold	1,000	–	–	﹤0.01%	1299
2018 Q3	$14K	Hold	1,000	–	–	﹤0.01%	1307
2018 Q2	$15K	Buy	+1,000	New	+$16.9K	﹤0.01%	1170

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Parallel Advisors's PLSE Position: Q1 2025 in Review

Parallel Advisors sold out of Pulse Biosciences (PLSE) in Q1 2025, closing a stake of 21 shares — an estimated $366 sold.

Parallel Advisors first reported a position in PLSE in Q2 2018 and held it in 15 quarters. The position peaked at $18K in Q1 2019. 84 funds tracked by Wall St. Rank hold PLSE as of Q1 2025.

Parallel Advisors reported no remaining Pulse Biosciences position as of Q1 2025 after selling out during the quarter.
Parallel Advisors sold 21 Pulse Biosciences shares in Q1 2025, an estimated $366.
Parallel Advisors first reported a position in Pulse Biosciences in Q2 2018 and held it in 15 quarters.
Parallel Advisors's Pulse Biosciences position peaked at $18K in Q1 2019.
84 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2025.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.